Clinical trial IJB_2691
Phase 3 Randomized Study Comparing Nivolumab and Ipilimumab Combination vs Placebo in Participants with Localized Renal Cell Carcinoma Who Underwent Radical or Partial Nephrectomy and Who Are at High Risk of Relapse
| Cancers | |
|---|---|
| Organ | Kidney |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | BMS - Bristol Myers Squibb int. |
| EudraCT Identifier | 2016-004502-34 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03138512 |
| Inclusion criteria | "Adjuvant", healthy margin |
| Last update |